This would be the case, given administration in a timely way at effective concentrations that can be made bioavailable. So there is a large gap between what might be useful theoretically based on in vitro observations and having a robust reliable therapy that can be administered with an understanding of the optimum route of administration and regimen with respect to concentration and frequency to maintain active levels within the bodily tissues to counter exposure to the virus within the body. So this is only in the raw stages of consideration. There are other issues always, as well. One is the ability to produce sufficient quantities to make this widely available versus a custom process that might be produced by a homebrew for a few recipients, but here again, without formal study and careful scientific measurements people will be working in the dark about what is truly going to work and how to do it so that happens.
Please login or Register to submit your answer